Revamping US pharma manufacturing: Trump’s executive order faces industry doubts
The executive order instructs the FDA to expedite the approval process for domestic pharmaceutical manufacturing facilities.
The executive order instructs the FDA to expedite the approval process for domestic pharmaceutical manufacturing facilities.
What's Your Reaction?
